nodes	percent_of_prediction	percent_of_DWPC	metapath
Triflupromazine—DRD2—Gilles de la Tourette syndrome	0.848	1	CbGaD
Triflupromazine—DRD1—Dopamine receptors—DRD3—Gilles de la Tourette syndrome	0.00752	0.0603	CbGpPWpGaD
Triflupromazine—DRD1—Dopamine receptors—DRD4—Gilles de la Tourette syndrome	0.0073	0.0585	CbGpPWpGaD
Triflupromazine—DRD1—Dopamine receptors—DRD2—Gilles de la Tourette syndrome	0.0068	0.0545	CbGpPWpGaD
Triflupromazine—DRD2—Dopamine receptors—DRD3—Gilles de la Tourette syndrome	0.00568	0.0455	CbGpPWpGaD
Triflupromazine—DRD2—Dopamine receptors—DRD4—Gilles de la Tourette syndrome	0.00551	0.0442	CbGpPWpGaD
Triflupromazine—BCHE—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—Gilles de la Tourette syndrome	0.00455	0.0365	CbGpPWpGaD
Triflupromazine—HTR2B—Serotonin receptors—HTR2A—Gilles de la Tourette syndrome	0.00251	0.0201	CbGpPWpGaD
Triflupromazine—HTR2B—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00207	0.0166	CbGpPWpGaD
Triflupromazine—DRD1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00195	0.0156	CbGpPWpGaD
Triflupromazine—DRD2—Nicotine Activity on Dopaminergic Neurons—DRD3—Gilles de la Tourette syndrome	0.0018	0.0144	CbGpPWpGaD
Triflupromazine—HTR2B—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00176	0.0141	CbGpPWpGaD
Triflupromazine—DRD2—Nicotine Activity on Dopaminergic Neurons—DRD4—Gilles de la Tourette syndrome	0.00175	0.014	CbGpPWpGaD
Triflupromazine—HTR2B—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00171	0.0137	CbGpPWpGaD
Triflupromazine—HTR2B—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HTR2A—Gilles de la Tourette syndrome	0.00167	0.0134	CbGpPWpGaD
Triflupromazine—DRD1—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00166	0.0133	CbGpPWpGaD
Triflupromazine—DRD1—Hypothetical Network for Drug Addiction—DRD4—Gilles de la Tourette syndrome	0.00165	0.0133	CbGpPWpGaD
Triflupromazine—DRD1—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00161	0.0129	CbGpPWpGaD
Triflupromazine—HTR2B—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00159	0.0128	CbGpPWpGaD
Triflupromazine—DRD1—Hypothetical Network for Drug Addiction—DRD2—Gilles de la Tourette syndrome	0.00154	0.0124	CbGpPWpGaD
Triflupromazine—DRD1—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0015	0.0121	CbGpPWpGaD
Triflupromazine—HTR2B—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00148	0.0119	CbGpPWpGaD
Triflupromazine—DRD2—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00147	0.0118	CbGpPWpGaD
Triflupromazine—CHRM1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00144	0.0115	CbGpPWpGaD
Triflupromazine—HTR2B—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00144	0.0115	CbGpPWpGaD
Triflupromazine—CHRM2—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00142	0.0114	CbGpPWpGaD
Triflupromazine—DRD1—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0014	0.0112	CbGpPWpGaD
Triflupromazine—DRD1—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00136	0.0109	CbGpPWpGaD
Triflupromazine—HTR2B—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00134	0.0107	CbGpPWpGaD
Triflupromazine—DRD1—midbrain—Gilles de la Tourette syndrome	0.00132	0.0781	CbGeAlD
Triflupromazine—DRD1—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00126	0.0101	CbGpPWpGaD
Triflupromazine—DRD2—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00125	0.0101	CbGpPWpGaD
Triflupromazine—DRD2—Hypothetical Network for Drug Addiction—DRD4—Gilles de la Tourette syndrome	0.00125	0.01	CbGpPWpGaD
Triflupromazine—CHRM1—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00123	0.00985	CbGpPWpGaD
Triflupromazine—DRD2—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00122	0.00977	CbGpPWpGaD
Triflupromazine—CHRM2—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00121	0.00972	CbGpPWpGaD
Triflupromazine—CHRM1—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00119	0.00956	CbGpPWpGaD
Triflupromazine—CHRM2—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00118	0.00944	CbGpPWpGaD
Triflupromazine—HTR2B—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00112	0.00895	CbGpPWpGaD
Triflupromazine—CHRM1—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00111	0.0089	CbGpPWpGaD
Triflupromazine—CHRM2—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0011	0.00879	CbGpPWpGaD
Triflupromazine—DRD1—nervous system—Gilles de la Tourette syndrome	0.00108	0.0642	CbGeAlD
Triflupromazine—DRD2—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00105	0.00846	CbGpPWpGaD
Triflupromazine—DRD1—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00105	0.00844	CbGpPWpGaD
Triflupromazine—DRD1—central nervous system—Gilles de la Tourette syndrome	0.00104	0.0618	CbGeAlD
Triflupromazine—CHRM1—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00103	0.00828	CbGpPWpGaD
Triflupromazine—DRD2—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00102	0.00821	CbGpPWpGaD
Triflupromazine—CHRM2—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00102	0.00817	CbGpPWpGaD
Triflupromazine—CHRM1—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.001	0.00803	CbGpPWpGaD
Triflupromazine—CHRM2—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.000989	0.00793	CbGpPWpGaD
Triflupromazine—HTR2B—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000938	0.00752	CbGpPWpGaD
Triflupromazine—CHRM1—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.000933	0.00749	CbGpPWpGaD
Triflupromazine—CHRM2—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.000921	0.00739	CbGpPWpGaD
Triflupromazine—DRD1—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000885	0.00709	CbGpPWpGaD
Triflupromazine—CHRM2—nervous system—Gilles de la Tourette syndrome	0.000874	0.0517	CbGeAlD
Triflupromazine—CHRM2—central nervous system—Gilles de la Tourette syndrome	0.000841	0.0498	CbGeAlD
Triflupromazine—DRD1—brain—Gilles de la Tourette syndrome	0.000829	0.0491	CbGeAlD
Triflupromazine—CHRM1—nervous system—Gilles de la Tourette syndrome	0.000795	0.0471	CbGeAlD
Triflupromazine—DRD2—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.000795	0.00637	CbGpPWpGaD
Triflupromazine—HTR2B—nervous system—Gilles de la Tourette syndrome	0.000791	0.0468	CbGeAlD
Triflupromazine—DRD2—midbrain—Gilles de la Tourette syndrome	0.000779	0.0461	CbGeAlD
Triflupromazine—CHRM1—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.000778	0.00624	CbGpPWpGaD
Triflupromazine—CHRM2—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.000768	0.00616	CbGpPWpGaD
Triflupromazine—CHRM1—central nervous system—Gilles de la Tourette syndrome	0.000766	0.0453	CbGeAlD
Triflupromazine—HTR2B—central nervous system—Gilles de la Tourette syndrome	0.000762	0.0451	CbGeAlD
Triflupromazine—BCHE—midbrain—Gilles de la Tourette syndrome	0.000706	0.0418	CbGeAlD
Triflupromazine—DRD2—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000668	0.00536	CbGpPWpGaD
Triflupromazine—CHRM2—brain—Gilles de la Tourette syndrome	0.000668	0.0395	CbGeAlD
Triflupromazine—CHRM1—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000654	0.00524	CbGpPWpGaD
Triflupromazine—CHRM2—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000645	0.00517	CbGpPWpGaD
Triflupromazine—DRD2—nervous system—Gilles de la Tourette syndrome	0.00064	0.0379	CbGeAlD
Triflupromazine—DRD2—central nervous system—Gilles de la Tourette syndrome	0.000617	0.0365	CbGeAlD
Triflupromazine—CHRM1—brain—Gilles de la Tourette syndrome	0.000608	0.036	CbGeAlD
Triflupromazine—HTR2B—brain—Gilles de la Tourette syndrome	0.000605	0.0358	CbGeAlD
Triflupromazine—BCHE—nervous system—Gilles de la Tourette syndrome	0.000581	0.0344	CbGeAlD
Triflupromazine—BCHE—central nervous system—Gilles de la Tourette syndrome	0.000559	0.0331	CbGeAlD
Triflupromazine—CHRM2—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.000538	0.00432	CbGpPWpGaD
Triflupromazine—CHRM2—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.000523	0.00419	CbGpPWpGaD
Triflupromazine—DRD2—brain—Gilles de la Tourette syndrome	0.000489	0.029	CbGeAlD
Triflupromazine—Acetophenazine—DRD2—Gilles de la Tourette syndrome	0.000484	0.0461	CrCbGaD
Triflupromazine—BCHE—brain—Gilles de la Tourette syndrome	0.000444	0.0263	CbGeAlD
Triflupromazine—DRD1—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.000392	0.00314	CbGpPWpGaD
Triflupromazine—DRD1—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.00038	0.00305	CbGpPWpGaD
Triflupromazine—Mesoridazine—DRD3—Gilles de la Tourette syndrome	0.000376	0.0359	CrCbGaD
Triflupromazine—Propiomazine—DRD4—Gilles de la Tourette syndrome	0.000368	0.0351	CrCbGaD
Triflupromazine—Prochlorperazine—DRD3—Gilles de la Tourette syndrome	0.000364	0.0348	CrCbGaD
Triflupromazine—DRD1—Circadian rythm related genes—DRD2—Gilles de la Tourette syndrome	0.000354	0.00284	CbGpPWpGaD
Triflupromazine—BCHE—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.000347	0.00278	CbGpPWpGaD
Triflupromazine—CHRM2—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.000341	0.00273	CbGpPWpGaD
Triflupromazine—HTR2B—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00034	0.00273	CbGpPWpGaD
Triflupromazine—ABCB1—midbrain—Gilles de la Tourette syndrome	0.000337	0.0199	CbGeAlD
Triflupromazine—HTR2B—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00033	0.00265	CbGpPWpGaD
Triflupromazine—Cyamemazine—HTR2A—Gilles de la Tourette syndrome	0.00033	0.0315	CrCbGaD
Triflupromazine—Fluphenazine—DRD3—Gilles de la Tourette syndrome	0.00033	0.0314	CrCbGaD
Triflupromazine—DRD1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000321	0.00257	CbGpPWpGaD
Triflupromazine—Methotrimeprazine—DRD4—Gilles de la Tourette syndrome	0.000314	0.03	CrCbGaD
Triflupromazine—DRD1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000311	0.0025	CbGpPWpGaD
Triflupromazine—HTR2B—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000308	0.00247	CbGpPWpGaD
Triflupromazine—Chlorprothixene—DRD3—Gilles de la Tourette syndrome	0.0003	0.0286	CrCbGaD
Triflupromazine—DRD2—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.000296	0.00237	CbGpPWpGaD
Triflupromazine—HTR2B—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000291	0.00234	CbGpPWpGaD
Triflupromazine—DRD1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00029	0.00233	CbGpPWpGaD
Triflupromazine—CHRM1—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.000289	0.00232	CbGpPWpGaD
Triflupromazine—DRD2—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.000287	0.0023	CbGpPWpGaD
Triflupromazine—HTR2B—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000283	0.00227	CbGpPWpGaD
Triflupromazine—CHRM1—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.000281	0.00225	CbGpPWpGaD
Triflupromazine—HTR2B—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.000279	0.00223	CbGpPWpGaD
Triflupromazine—ABCB1—nervous system—Gilles de la Tourette syndrome	0.000277	0.0164	CbGeAlD
Triflupromazine—DRD1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000275	0.0022	CbGpPWpGaD
Triflupromazine—Acepromazine—DRD2—Gilles de la Tourette syndrome	0.000274	0.0262	CrCbGaD
Triflupromazine—Promazine—DRD4—Gilles de la Tourette syndrome	0.000272	0.026	CrCbGaD
Triflupromazine—Methotrimeprazine—DRD3—Gilles de la Tourette syndrome	0.000271	0.0259	CrCbGaD
Triflupromazine—Thioproperazine—DRD2—Gilles de la Tourette syndrome	0.000268	0.0256	CrCbGaD
Triflupromazine—DRD1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000267	0.00214	CbGpPWpGaD
Triflupromazine—ABCB1—central nervous system—Gilles de la Tourette syndrome	0.000266	0.0158	CbGeAlD
Triflupromazine—BCHE—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.000266	0.00213	CbGpPWpGaD
Triflupromazine—Pipotiazine—DRD2—Gilles de la Tourette syndrome	0.000264	0.0252	CrCbGaD
Triflupromazine—HTR2B—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000263	0.00211	CbGpPWpGaD
Triflupromazine—CHRM1—Circadian rythm related genes—DRD2—Gilles de la Tourette syndrome	0.000262	0.0021	CbGpPWpGaD
Triflupromazine—DRD2—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000261	0.00209	CbGpPWpGaD
Triflupromazine—Mesoridazine—DRD2—Gilles de la Tourette syndrome	0.00026	0.0248	CrCbGaD
Triflupromazine—DRD2—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000253	0.00203	CbGpPWpGaD
Triflupromazine—Prochlorperazine—DRD2—Gilles de la Tourette syndrome	0.000252	0.0241	CrCbGaD
Triflupromazine—CHRM2—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000252	0.00202	CbGpPWpGaD
Triflupromazine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.000249	0.002	CbGpPWpGaD
Triflupromazine—DRD1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000248	0.00199	CbGpPWpGaD
Triflupromazine—CHRM2—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000245	0.00196	CbGpPWpGaD
Triflupromazine—DRD2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000242	0.00194	CbGpPWpGaD
Triflupromazine—Chlorpromazine—DRD4—Gilles de la Tourette syndrome	0.00024	0.0229	CrCbGaD
Triflupromazine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000237	0.0019	CbGpPWpGaD
Triflupromazine—DRD2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000235	0.00188	CbGpPWpGaD
Triflupromazine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000234	0.00188	CbGpPWpGaD
Triflupromazine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00023	0.00184	CbGpPWpGaD
Triflupromazine—Fluphenazine—DRD2—Gilles de la Tourette syndrome	0.000228	0.0218	CrCbGaD
Triflupromazine—CHRM2—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.000228	0.00183	CbGpPWpGaD
Triflupromazine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000227	0.00182	CbGpPWpGaD
Triflupromazine—Desipramine—SLC6A3—Gilles de la Tourette syndrome	0.000226	0.0215	CrCbGaD
Triflupromazine—HTR2B—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000222	0.00178	CbGpPWpGaD
Triflupromazine—CHRM2—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.000222	0.00178	CbGpPWpGaD
Triflupromazine—Propiomazine—DRD2—Gilles de la Tourette syndrome	0.000219	0.0209	CrCbGaD
Triflupromazine—HTR2B—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000215	0.00173	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000215	0.00173	CbGpPWpGaD
Triflupromazine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000214	0.00172	CbGpPWpGaD
Triflupromazine—Acepromazine—HTR2A—Gilles de la Tourette syndrome	0.000212	0.0202	CrCbGaD
Triflupromazine—ABCB1—brain—Gilles de la Tourette syndrome	0.000212	0.0125	CbGeAlD
Triflupromazine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000212	0.0017	CbGpPWpGaD
Triflupromazine—DRD1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000209	0.00168	CbGpPWpGaD
Triflupromazine—Chlorprothixene—DRD2—Gilles de la Tourette syndrome	0.000208	0.0198	CrCbGaD
Triflupromazine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000207	0.00166	CbGpPWpGaD
Triflupromazine—Thioproperazine—HTR2A—Gilles de la Tourette syndrome	0.000207	0.0198	CrCbGaD
Triflupromazine—Chlorpromazine—DRD3—Gilles de la Tourette syndrome	0.000207	0.0197	CrCbGaD
Triflupromazine—Pipotiazine—HTR2A—Gilles de la Tourette syndrome	0.000204	0.0195	CrCbGaD
Triflupromazine—DRD1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000203	0.00163	CbGpPWpGaD
Triflupromazine—DRD1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000203	0.00163	CbGpPWpGaD
Triflupromazine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000203	0.00163	CbGpPWpGaD
Triflupromazine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000201	0.00161	CbGpPWpGaD
Triflupromazine—Mesoridazine—HTR2A—Gilles de la Tourette syndrome	0.000201	0.0192	CrCbGaD
Triflupromazine—HTR2B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000201	0.00161	CbGpPWpGaD
Triflupromazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.0002	0.00161	CbGpPWpGaD
Triflupromazine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000197	0.00158	CbGpPWpGaD
Triflupromazine—Thioridazine—DRD2—Gilles de la Tourette syndrome	0.000197	0.0187	CrCbGaD
Triflupromazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000195	0.00156	CbGpPWpGaD
Triflupromazine—CHRM1—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.000194	0.00156	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—HDC—Gilles de la Tourette syndrome	0.000192	0.00154	CbGpPWpGaD
Triflupromazine—Imipramine—SLC6A3—Gilles de la Tourette syndrome	0.000191	0.0183	CrCbGaD
Triflupromazine—DRD1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000189	0.00152	CbGpPWpGaD
Triflupromazine—Methotrimeprazine—DRD2—Gilles de la Tourette syndrome	0.000188	0.0179	CrCbGaD
Triflupromazine—Promethazine—DRD2—Gilles de la Tourette syndrome	0.000185	0.0176	CrCbGaD
Triflupromazine—HTR2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000185	0.00148	CbGpPWpGaD
Triflupromazine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000184	0.00147	CbGpPWpGaD
Triflupromazine—Trifluoperazine—DRD2—Gilles de la Tourette syndrome	0.000182	0.0174	CrCbGaD
Triflupromazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000181	0.00145	CbGpPWpGaD
Triflupromazine—Perphenazine—DRD2—Gilles de la Tourette syndrome	0.00018	0.0172	CrCbGaD
Triflupromazine—Fluphenazine—HTR2A—Gilles de la Tourette syndrome	0.000176	0.0168	CrCbGaD
Triflupromazine—DRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000174	0.0014	CbGpPWpGaD
Triflupromazine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.000174	0.00139	CbGpPWpGaD
Triflupromazine—Propiomazine—HTR2A—Gilles de la Tourette syndrome	0.00017	0.0162	CrCbGaD
Triflupromazine—Desipramine—DRD2—Gilles de la Tourette syndrome	0.000168	0.016	CrCbGaD
Triflupromazine—Promazine—DRD2—Gilles de la Tourette syndrome	0.000163	0.0155	CrCbGaD
Triflupromazine—Clomipramine—HTR2A—Gilles de la Tourette syndrome	0.000161	0.0154	CrCbGaD
Triflupromazine—Chlorprothixene—HTR2A—Gilles de la Tourette syndrome	0.000161	0.0153	CrCbGaD
Triflupromazine—DRD2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000158	0.00127	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000155	0.00124	CbGpPWpGaD
Triflupromazine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000153	0.00123	CbGpPWpGaD
Triflupromazine—DRD2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000153	0.00123	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000153	0.00122	CbGpPWpGaD
Triflupromazine—Thioridazine—HTR2A—Gilles de la Tourette syndrome	0.000152	0.0145	CrCbGaD
Triflupromazine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00015	0.0012	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00015	0.0012	CbGpPWpGaD
Triflupromazine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000148	0.00119	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000148	0.00119	CbGpPWpGaD
Triflupromazine—Methotrimeprazine—HTR2A—Gilles de la Tourette syndrome	0.000145	0.0138	CrCbGaD
Triflupromazine—Chlorpromazine—DRD2—Gilles de la Tourette syndrome	0.000143	0.0136	CrCbGaD
Triflupromazine—Promethazine—HTR2A—Gilles de la Tourette syndrome	0.000143	0.0136	CrCbGaD
Triflupromazine—Imipramine—DRD2—Gilles de la Tourette syndrome	0.000142	0.0136	CrCbGaD
Triflupromazine—Trifluoperazine—HTR2A—Gilles de la Tourette syndrome	0.000141	0.0134	CrCbGaD
Triflupromazine—HTR2B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000141	0.00113	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00014	0.00112	CbGpPWpGaD
Triflupromazine—Perphenazine—HTR2A—Gilles de la Tourette syndrome	0.000139	0.0133	CrCbGaD
Triflupromazine—CHRM2—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000138	0.00111	CbGpPWpGaD
Triflupromazine—DRD1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000133	0.00106	CbGpPWpGaD
Triflupromazine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000131	0.00105	CbGpPWpGaD
Triflupromazine—Desipramine—HTR2A—Gilles de la Tourette syndrome	0.00013	0.0124	CrCbGaD
Triflupromazine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000129	0.00103	CbGpPWpGaD
Triflupromazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000127	0.00102	CbGpPWpGaD
Triflupromazine—Promazine—HTR2A—Gilles de la Tourette syndrome	0.000126	0.012	CrCbGaD
Triflupromazine—HTR2B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000125	0.00101	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000122	0.000976	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000118	0.000948	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000115	0.00092	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000114	0.000913	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000113	0.000909	CbGpPWpGaD
Triflupromazine—Chlorpromazine—HTR2A—Gilles de la Tourette syndrome	0.000111	0.0105	CrCbGaD
Triflupromazine—HTR2B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000111	0.000886	CbGpPWpGaD
Triflupromazine—Imipramine—HTR2A—Gilles de la Tourette syndrome	0.00011	0.0105	CrCbGaD
Triflupromazine—DRD1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000107	0.000861	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000107	0.000857	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000104	0.000836	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000103	0.000826	CbGpPWpGaD
Triflupromazine—DRD2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.0001	0.000802	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	9.79e-05	0.000785	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	9.71e-05	0.000779	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	9.67e-05	0.000775	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—HDC—Gilles de la Tourette syndrome	9.38e-05	0.000752	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	8.93e-05	0.000716	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	8.74e-05	0.000701	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	8.67e-05	0.000695	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	8.62e-05	0.000692	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	8.48e-05	0.00068	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	8.37e-05	0.000671	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	8.11e-05	0.00065	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	7.94e-05	0.000637	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	7.93e-05	0.000636	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	7.9e-05	0.000634	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	7.87e-05	0.000631	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	7.83e-05	0.000628	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	7.8e-05	0.000625	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	7.7e-05	0.000618	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	7.6e-05	0.00061	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	7.49e-05	0.000601	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	7.21e-05	0.000578	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	7.18e-05	0.000575	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	7.08e-05	0.000568	CbGpPWpGaD
Triflupromazine—ABCB1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	6.97e-05	0.000559	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	6.8e-05	0.000545	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	6.73e-05	0.000539	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	6.53e-05	0.000524	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	6.34e-05	0.000509	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	6.16e-05	0.000494	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	6.08e-05	0.000488	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	5.74e-05	0.00046	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	5.65e-05	0.000453	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	5.53e-05	0.000444	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	5.46e-05	0.000438	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	5.13e-05	0.000412	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	5.03e-05	0.000403	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	4.96e-05	0.000398	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	4.79e-05	0.000384	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	4.69e-05	0.000376	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	4.65e-05	0.000373	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	4.63e-05	0.000371	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	4.55e-05	0.000365	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	4.49e-05	0.00036	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	4.26e-05	0.000342	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	4.24e-05	0.00034	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	4.18e-05	0.000336	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	4.02e-05	0.000322	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	3.03e-05	0.000243	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.97e-05	0.000238	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.93e-05	0.000235	CbGpPWpGaD
